Funding round

Thyme Care raises >$125M Series E round

Thyme Care (United States) has raised >$125M in a Series E round, announced on September 2, 2026. The company is Provides technology-enabled oncology care navigation and cost management services. The round was led by Morgan Health, with participation from Humana, CVS Health Ventures, AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures, a16z Bio + Health.

Thyme Care will use the Series E financing to accelerate growth and establish Thyme Companies for additional oncology businesses.

Company

Thyme Care

Amount

>$125M (~$125M)

Round

Series E

Sector

Oncology healthcare

Country

United States

Announced

September 2, 2026

Track every raise, every day

This deal appeared in The Daily Raise, September 2, 2026. Get the next edition in your inbox.

Just raised too?

Turn your funding news into guaranteed media coverage while the momentum lasts.

Get featured